Literature DB >> 2804028

A point prevalence study of 150 patients with idiopathic retinal vasculitis: 2. Clinical relevance of antiretinal autoimmunity and circulating immune complexes.

E Kasp1, E M Graham, M R Stanford, M D Sanders, D C Dumonde.   

Abstract

This study describes the occurrence of antiretinal antibodies and circulating immune complexes in the sera of a large series of patients with idiopathic retinal vasculitis whose ophthalmological and clinical features are presented in Part 1. Antiretinal antibodies were measured by indirect immunofluorescence and passive haemagglutination, and circulating immune complexes were measured by polyethylene glycol precipitation and Clq binding. The occurrence of antiretinal antibodies and that of circulating immune complexes were analysed in relation to each other, to severity of retinal disease, to the type of associated systemic inflammatory disease, and to the presence of individual features of retinal inflammation. In patients with retinal vasculitis together with systemic inflammatory disease circulating immune complexes were usually accompanied by antiretinal antibodies. However, those patients with antiretinal antibodies in the absence of circulating immune complexes tended to have more severe retinal vasculitis, a feature particularly evident in Behçet's disease (p = 0.028). In patients with isolated retinal vasculitis, severity of disease was associated with antiretinal antibody (p = 0.013), as well as with the occurrence of both antiretinal antibody and circulating immune complexes together (p = 0.010). In the series as a whole there was a tendency for individual features of retinal vasculitis to be associated with antiretinal antibodies unaccompanied by circulating immune complexes; especially in macular oedema (p = 0.028). In isolated retinal vasculitis there was also an additive effect of antiretinal antibodies and circulating immune complexes in relation to disease severity; in contrast, in patients with systemic inflammatory disease, the coexistence of antiretinal antibodies and concluded that both antiretinal autoimmunity and circulating immune complexes may act as immunopathogenetic factors in idiopathic retinal vasculitis but that, in certain patients, circulating immune complex formation seems to protect against the more severe forms of autoimmune retinal inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2804028      PMCID: PMC1041866          DOI: 10.1136/bjo.73.9.722

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  12 in total

1.  Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q.

Authors:  F C Hay; L J Nineham; I M Roitt
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

2.  An improved method for the purification of retinal S-antigen using selective hydrophobic adsorption chromatography.

Authors:  E Kasp; J P Banga; E C Brown; J M Wicking; S Suleyman; B A Ellis; M D Sanders; D C Dumonde
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

3.  Immune complexes in uveitis.

Authors:  D H Char; P Stein; R Masi; M Christensen
Journal:  Am J Ophthalmol       Date:  1979-05       Impact factor: 5.258

4.  Immune complexes in ovarian cancer.

Authors:  T A Poulton; M E Crowther; F C Hay; L J Nineham
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

Review 5.  Duke-Elder lecture. Retinal arteritis, retinal vasculitis and autoimmune retinal vasculitis.

Authors:  M D Sanders
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775

6.  A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features.

Authors:  E M Graham; M R Stanford; M D Sanders; E Kasp; D C Dumonde
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

7.  Humoral and cellular immune responsiveness to human S-antigen in uveitis.

Authors:  G Doekes; R van der Gaag; A Rothova; Y van Kooyk; L Broersma; M J Zaal; G Dijkman; M E Fortuin; G S Baarsma; A Kijlstra
Journal:  Curr Eye Res       Date:  1987-07       Impact factor: 2.424

8.  Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia.

Authors:  C C Chan; A G Palestine; R B Nussenblatt; F G Roberge; D Benezra
Journal:  Ophthalmology       Date:  1985-08       Impact factor: 12.079

9.  Serum antibody levels of uveitis patients to bovine retinal antigens.

Authors:  D S Gregerson; I W Abrahams; C E Thirkill
Journal:  Invest Ophthalmol Vis Sci       Date:  1981-11       Impact factor: 4.799

10.  Cellular immune responsiveness of uveitis patients to retinal S-antigen.

Authors:  R B Nussenblatt; I Gery; E J Ballintine; W B Wacker
Journal:  Am J Ophthalmol       Date:  1980-02       Impact factor: 5.258

View more
  3 in total

1.  Retinal vasculitis and vitreous hemorrhage associated with mixed connective tissue disease: retinal vasculitis in MCTD.

Authors:  Tatsuya Mimura; Tomohiko Usui; Shiro Amano; Satoru Yamagami; Kyoko Ono; Hidetaka Noma; Hideharu Funatsu
Journal:  Int Ophthalmol       Date:  2007-01-03       Impact factor: 2.031

2.  Circulating immune complexes may play a regulatory and pathogenic role in experimental autoimmune uveoretinitis.

Authors:  E Kasp; M R Stanford; E Brown; A G Coombes; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

Review 3.  An Overview of Venous Abnormalities Related to the Development of Lesions in Multiple Sclerosis.

Authors:  E Mark Haacke; Yulin Ge; Sean K Sethi; Sagar Buch; Paolo Zamboni
Journal:  Front Neurol       Date:  2021-04-26       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.